Tesamorelin
N-terminally acylated GHRH analog · active ingredient in approved HIV-lipodystrophy products
- Purity
- Target ≥ 99.0% · Batch COA
- CAS
- 218949-48-5
Research categories
Scientific identifiers, sequences and source publication titles are retained in their original form.
N-terminally acylated GHRH analog · active ingredient in approved HIV-lipodystrophy products
Unvalidated two-peptide GH-axis research blend (CJC-1295 no DAC plus ipamorelin)
Modified human-growth-hormone fragment 176–191 · investigational metabolic research peptide
DAC-modified tetrasubstituted GRF(1-29) analogue · research use only
Tetrasubstituted GRF(1-29) analogue · no DAC · research use only
Pralmorelin (GHRP-2) hexapeptide research reference · approved Japanese diagnostic product context is not transferable
GHRP-6 amidated hexapeptide research reference · free-base and triacetate forms must be distinguished
Stereochemically defined GHSR agonist hexapeptide (hexarelin/examorelin)
Long R3 IGF-I · 83-residue IGF-I analogue for cell-culture and receptor research
Stereochemically defined GHSR agonist pentapeptide
Synthetic 24-residue IGF-1Ec E-domain research peptide
Amidated human GHRH(1-29) research reference
Two-component GH-axis research pairing · no direct evidence for the exact combination
Tesamorelin–ipamorelin two-component research blend · “IP5” shorthand is not inositol pentaphosphate